Efficacy of the Gelstix nucleus augmentation device for the treatment of chronic discogenic low back pain: protocol for a randomised, sham-controlled, double-blind, multicentre trial

INTRODUCTION: Discogenic pain is the cause of pain in 26%–40% of patients with for low back pain. Consensus about treatment of chronic discogenic low back pain is lacking and most treatment alternatives are supported by limited evidence. The percutaneous implantation of hydrogels into the nucleus pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Koetsier, Eva, van Kuijk, Sander M J, Maino, Paolo, Dukanac, Jasmina, Scascighini, Luca, Cianfoni, Alessandro, Scarone, Pietro, Kuhlen, Dominique E, Hollman, Markus W, Kallewaard, Jan-Willem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Anaesthesia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968527/
https://www.ncbi.nlm.nih.gov/pubmed/35354635
http://dx.doi.org/10.1136/bmjopen-2021-053772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968527/
https://www.ncbi.nlm.nih.gov/pubmed/35354635
http://dx.doi.org/10.1136/bmjopen-2021-053772

Ejemplares similares